Biohaven Reports Recent Business Developments and Third Quarter 2026 Financial Results

The Quick Take
The US Food and Drug Administration (FDA) accepted new drug application resubmission for Vyglxia (troriluzole) in spinocerebeller ataxia (SCA), user fee goal date 1Q27. Announced exclusive global license with SK Biopharmaceuticals Co., Ltd. for Kv7 ion channel platform, including opakalim...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Business
BMO Closes Sale of Transportation and Vendor Finance Businesses
TORONTO and CHICAGO, Oct. 29, 2026 /PRNewswire/ -- BMO Financial Group (TSX: BMO) (NYSE: BMO) today announced it has closed the previously announced sale of…
Business
American Design Hub Launches Business Starter Pack for Small Business Owners Ahead of the Holiday Season - EIN News
American Design Hub Launches Business Starter Pack for Small Business Owners Ahead of the Holiday Season EIN News
Local
100+ small businesses have signed pledge to protect free and democratic elections - Midway Como Frogtown Monitor
100+ small businesses have signed pledge to protect free and democratic elections Midway Como Frogtown Monitor
Business
